Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration

A Flow Cytometric Study

Marina Wolf, Michael J. Zigmond, Gregory Kapatos

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Fluorescence‐activated cell sorting based on im‐munolabeling with a monoclonal antibody to tyrosine hydroxylase and a fluorescein‐conjugated secondary antibody was used to identify striatal synaptosomes derived from ni‐grostriatal dopamine nerve terminals. The amount of tyrosine hydroxylase immunoreactivity in dopaminergic striatal synaptosomes prepared from control rats was compared to the amount in dopaminergic synaptosomes prepared from rats that had received intraventricular injections of 6‐hydroxy‐dopamine. Although the absolute number of dopaminergic synaptosomes was decreased in lesioned animals, those residual dopamine terminals present contained more tyrosine hydroxylase than did dopamine terminals from control rats. Both the decrease in the absolute number of dopamine terminals and the increase in tyrosine hydroxylase immunoreactivity in residual terminals were proportional to the extent of the lesion, as determined by measurement of striatal dopamine levels. These results suggest that an increase in the amount of tyrosine hydroxylase protein in residual terminals may represent one compensatory mechanism by which residual dopamine neurons maintain normal striatal function after partial destruction of the nigrostriatal dopamine projection.

Original languageEnglish (US)
Pages (from-to)879-885
Number of pages7
JournalJournal of Neurochemistry
Volume53
Issue number3
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Corpus Striatum
Tyrosine 3-Monooxygenase
Dopamine
Synaptosomes
Rat control
Intraventricular Injections
Dopaminergic Neurons
Sorting
Neurons
Rats
Monoclonal Antibodies
Animals
Cells
Antibodies
Proteins

Keywords

  • 6‐Hydroxydopamine
  • Flow cytometry
  • Nigrostriatal dopamine neurons
  • Synaptosomes
  • Tyrosine hydroxylase

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration : A Flow Cytometric Study. / Wolf, Marina; Zigmond, Michael J.; Kapatos, Gregory.

In: Journal of Neurochemistry, Vol. 53, No. 3, 01.01.1989, p. 879-885.

Research output: Contribution to journalArticle

@article{83dc65eceddd4032b6122c2e858d5397,
title = "Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration: A Flow Cytometric Study",
abstract = "Fluorescence‐activated cell sorting based on im‐munolabeling with a monoclonal antibody to tyrosine hydroxylase and a fluorescein‐conjugated secondary antibody was used to identify striatal synaptosomes derived from ni‐grostriatal dopamine nerve terminals. The amount of tyrosine hydroxylase immunoreactivity in dopaminergic striatal synaptosomes prepared from control rats was compared to the amount in dopaminergic synaptosomes prepared from rats that had received intraventricular injections of 6‐hydroxy‐dopamine. Although the absolute number of dopaminergic synaptosomes was decreased in lesioned animals, those residual dopamine terminals present contained more tyrosine hydroxylase than did dopamine terminals from control rats. Both the decrease in the absolute number of dopamine terminals and the increase in tyrosine hydroxylase immunoreactivity in residual terminals were proportional to the extent of the lesion, as determined by measurement of striatal dopamine levels. These results suggest that an increase in the amount of tyrosine hydroxylase protein in residual terminals may represent one compensatory mechanism by which residual dopamine neurons maintain normal striatal function after partial destruction of the nigrostriatal dopamine projection.",
keywords = "6‐Hydroxydopamine, Flow cytometry, Nigrostriatal dopamine neurons, Synaptosomes, Tyrosine hydroxylase",
author = "Marina Wolf and Zigmond, {Michael J.} and Gregory Kapatos",
year = "1989",
month = "1",
day = "1",
doi = "10.1111/j.1471-4159.1989.tb11786.x",
language = "English (US)",
volume = "53",
pages = "879--885",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6‐Hydroxydopamine Administration

T2 - A Flow Cytometric Study

AU - Wolf, Marina

AU - Zigmond, Michael J.

AU - Kapatos, Gregory

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Fluorescence‐activated cell sorting based on im‐munolabeling with a monoclonal antibody to tyrosine hydroxylase and a fluorescein‐conjugated secondary antibody was used to identify striatal synaptosomes derived from ni‐grostriatal dopamine nerve terminals. The amount of tyrosine hydroxylase immunoreactivity in dopaminergic striatal synaptosomes prepared from control rats was compared to the amount in dopaminergic synaptosomes prepared from rats that had received intraventricular injections of 6‐hydroxy‐dopamine. Although the absolute number of dopaminergic synaptosomes was decreased in lesioned animals, those residual dopamine terminals present contained more tyrosine hydroxylase than did dopamine terminals from control rats. Both the decrease in the absolute number of dopamine terminals and the increase in tyrosine hydroxylase immunoreactivity in residual terminals were proportional to the extent of the lesion, as determined by measurement of striatal dopamine levels. These results suggest that an increase in the amount of tyrosine hydroxylase protein in residual terminals may represent one compensatory mechanism by which residual dopamine neurons maintain normal striatal function after partial destruction of the nigrostriatal dopamine projection.

AB - Fluorescence‐activated cell sorting based on im‐munolabeling with a monoclonal antibody to tyrosine hydroxylase and a fluorescein‐conjugated secondary antibody was used to identify striatal synaptosomes derived from ni‐grostriatal dopamine nerve terminals. The amount of tyrosine hydroxylase immunoreactivity in dopaminergic striatal synaptosomes prepared from control rats was compared to the amount in dopaminergic synaptosomes prepared from rats that had received intraventricular injections of 6‐hydroxy‐dopamine. Although the absolute number of dopaminergic synaptosomes was decreased in lesioned animals, those residual dopamine terminals present contained more tyrosine hydroxylase than did dopamine terminals from control rats. Both the decrease in the absolute number of dopamine terminals and the increase in tyrosine hydroxylase immunoreactivity in residual terminals were proportional to the extent of the lesion, as determined by measurement of striatal dopamine levels. These results suggest that an increase in the amount of tyrosine hydroxylase protein in residual terminals may represent one compensatory mechanism by which residual dopamine neurons maintain normal striatal function after partial destruction of the nigrostriatal dopamine projection.

KW - 6‐Hydroxydopamine

KW - Flow cytometry

KW - Nigrostriatal dopamine neurons

KW - Synaptosomes

KW - Tyrosine hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=0024311918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024311918&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.1989.tb11786.x

DO - 10.1111/j.1471-4159.1989.tb11786.x

M3 - Article

VL - 53

SP - 879

EP - 885

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -